We need more support and doctors that understand the process of tapering

We need more support and doctors that understand the process of tapering

A content analysis of free-text responses to a questionnaire on discontinuing long-term benzodiazepine receptor agonist (BZRA) Use A group of researchers, including Benzodiazepine Information Coalitionā€™s Medical Director, Dr. Christy Huff, along with Tom Lynch, CristĆ­n…

The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs

The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs

The first edition of The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids, and Z-drugs is now available!  Authored by Mark Horowitz, a Clinical Research Fellow and training psychiatrist with specialized knowledge in deprescribing, along with David Taylor, a Professor of…

Summarizing the World Health Organization’s 2023 Benzodiazepine Guidelines

Summarizing the World Health Organization’s 2023 Benzodiazepine Guidelines

On November 20, 2023, the World Health Organization’s (WHO) 2023 (Third Edition) Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological, and substance use disorders introduced revised guidelines. The mhGAP guideline supports countries to…

HHA, SAMHSA 2022 National Survey on Drug Use Finds Low Benzodiazepine Misuse

HHA, SAMHSA 2022 National Survey on Drug Use Finds Low Benzodiazepine Misuse

On November 13, 2023, the U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), released a report titled “Key Substance Use and Mental Health Indicators in…